Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Local Health Unit-Azienda Sanitaria Locale Roma 2, Rome, Italy.
PLoS One. 2020 Apr 2;15(4):e0230749. doi: 10.1371/journal.pone.0230749. eCollection 2020.
The international public health (PH) community is debating the opportunity to incorporate genomic technologies into PH practice. A survey was conducted to assess attitudes of the European Public Health Association (EUPHA) members towards their role in the implementation of public health genomics (PHG), and their knowledge and attitudes towards genetic testing and the delivery of genetic services.
EUPHA members were invited via monthly newsletter and e-mail to take part in an online survey from February 2017 to January 2018. A descriptive analysis of knowledge and attitudes was conducted, along with a univariate and multivariate analysis of their determinants.
Five hundred and two people completed the questionnaire, 17.9% were involved in PHG activities. Only 28.9% correctly identified all medical conditions for which there is (or not) evidence for implementing genetic testing; over 60% thought that investing in genomics may divert economic resources from social and environmental determinants of health. The majority agreed that PH professionals may play different roles in incorporating genomics into their activities. Better knowledge was associated with positive attitudes towards the use of genetic testing and the delivery of genetic services in PH (OR = 1.48; 95% CI 1.01-2.18).
Our study revealed quite positive attitudes, but also a need to increase awareness on genomics among European PH professionals. Those directly involved in PHG activities tend to have a more positive attitude and better knowledge; however, gaps are also evident in this group, suggesting the need to harmonize practice and encourage greater exchange of knowledge among professionals.
国际公共卫生(PH)界正在讨论将基因组技术纳入 PH 实践的机会。进行了一项调查,以评估欧洲公共卫生协会(EUPHA)成员对其在实施公共卫生基因组学(PHG)方面的作用的态度,以及他们对遗传检测和遗传服务提供的知识和态度。
通过每月的通讯和电子邮件邀请 EUPHA 成员参加 2017 年 2 月至 2018 年 1 月的在线调查。对知识和态度进行描述性分析,并对其决定因素进行单变量和多变量分析。
502 人完成了问卷,17.9%的人参与了 PHG 活动。只有 28.9%的人正确识别了所有有(或没有)证据实施遗传检测的医疗条件;超过 60%的人认为投资于基因组学可能会将经济资源从社会和环境健康决定因素转移走。大多数人认为 PH 专业人员在将基因组学纳入其活动中可能扮演不同的角色。更好的知识与在 PH 中使用遗传检测和提供遗传服务的积极态度相关(OR = 1.48;95%CI 1.01-2.18)。
我们的研究表明,态度相当积极,但欧洲 PH 专业人员也需要提高对基因组学的认识。那些直接参与 PHG 活动的人往往具有更积极的态度和更好的知识;然而,在这个群体中也存在明显的差距,这表明需要协调实践,并鼓励专业人员之间更多地交流知识。